Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 8/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2494588 | 0.84 | MEN1 (0.51) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL9617201 | 0.83 | MAPT (0.54) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL8822084 | 0.80 | MAPT (0.48) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL8520463 | 0.79 | KDM4E (0.49) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL15549323 | 0.78 | MAPT (0.62) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL9193182 | 0.78 | RAB9A (0.45) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL27560797 | 0.76 | MAPT (0.59) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL19591528 | 0.76 | MAPT (0.59) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL28002084 | 0.76 | MAPT (0.59) | LMNAMEN1KMT2AKDM4EMAPT | |
| SCHEMBL11400893 | 0.73 | MAPT (0.60) | LMNAMEN1KMT2AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4985470-A | Three component photoinitiator system, printing plates, photoresists, inks, paints, adhesives | MITSUBISHI KASEI CORPORATION (JP) | 1991-01-15 | — | — | US | claimed |
| US-12559468-B2 | Method for producing organic compound | DAIKIN INDUSTRIES, LTD. (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-4257576-A2 | METHOD FOR PRODUCING ORGANIC COMPOUND | Daikin Industries, Ltd. (JP) | 2023-10-11 | — | — | EP | disclosed |
| EP-3922625-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2021-12-15 | — | — | EP | disclosed |
| US-20210371391-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2021-12-02 | — | — | US | disclosed |
| CN-113412249-A | Method for producing organic compound | 大金工业株式会社 | 2021-09-17 | — | — | CN | disclosed |
| CN-107561858-B | Polyimide dry film and use thereof | 长兴材料工业股份有限公司 | 2021-01-08 | — | — | CN | disclosed |
| WO-2020162630-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | ダイキン工業株式会社 | 2020-08-13 | — | — | WO | disclosed |
| US-10639876-B2 | Solvent-containing dry film and method for applying the same on a substrate | ETERNAL MATERIALS CO., LTD. (TW) | 2020-05-05 | — | — | US | disclosed |
| US-10590305-B2 | Polyimide dry film and application thereof | ETERNAL MATERIALS CO., LTD. (TW) | 2020-03-17 | — | — | US | disclosed |
| EP-0814109-A1 | Photosensitive polyimide precursor and its use for pattern formation | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0532798-B1 | An electroluminescent element | ASAHI CHEMICAL IND (JP) | 1995-12-06 | — | — | EP | disclosed |
| US-5281489-A | Anode, cathode, organic luminescent layer disposed between, the luminescent layer comprising a fluorescent luminescent agent, a hole moving and donating agent, an electron moving and donating agent | ASASHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1994-01-25 | — | — | US | disclosed |
| EP-0532798-A1 | An electroluminescent element | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1993-03-24 | — | — | EP | disclosed |
| EP-0475086-A1 | Photo-sensitive polymer composition | HITACHI, LTD. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-4987056-A | IMPROVED SENSITIVITY TO VISIBLE LIGHT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4985470-A | Three component photoinitiator system, printing plates, photoresists, inks, paints, adhesives | MITSUBISHI KASEI CORPORATION (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0107792-B1 | PHOTOPOLYMERIZABLE COMPOSITIONS | MITSUBISHI KASEI CORPORATION (JP) | 1985-12-27 | — | — | EP | disclosed |
| US-4021246-A | LEUCO DYES | HORIZONS INCORPORATED, A DIVISION OF HORIZONS RESEARCH INCORPORATED (US) | 1977-05-03 | — | — | US | disclosed |
| US-4018604-A | METAL DITHIOCARBAMATES-DITHIOPHOSPHINATES TO PREVENT FOGGING | HORIZONS INCORPORATED, A DIVISION OF HORIZONS RESEARCH INCORPORATED (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210371391-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | PHF2, CYP2F1, INF2 | LMNA 2822/4885MEN1 202/4885KMT2A 287/4885 |
| US-12559468-B2 | Method for producing organic compound | FOXM1, FOXO3, FOXO1 | LMNA 1947/4885MEN1 693/4885KMT2A 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.